Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients - Sabbatinelli, Jacopo; Giuliani, Angelica; Matacchione, Giulia; Latini, Silvia; Laprovitera, Noemi; Pomponio, Giovanni; Ferrarini, Alessia; Svegliati Baroni, Silvia; Pavani, Marianna; Moretti, Marco; Gabrielli, Armando; Procopio, Antonio Domenico; et al. (Mechanisms of ageing and development, 2021)
Keywords: Adult; Aged; Antibodies, Monoclonal, Humanized - administration & dosage; Biomarkers - blood; Circulating MicroRNA - blood; COVID-19; COVID-19 - blood; COVID-19 - drug therapy; COVID-19 - epidemiology; Female; Humans; Inflammaging; Inflammation - blood; Inflammation - drug therapy; Inflammation - epidemiology; interleukin-6; Male; microRNA; MicroRNAs - blood; Middle Aged; Pandemics; SARS-CoV-2; Tocilizumab; COVID-19; microRNA; Inflammaging; Tocilizumab; interleukin-6